KR102324922B9 - 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물 - Google Patents

오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물

Info

Publication number
KR102324922B9
KR102324922B9 KR1020200102684A KR20200102684A KR102324922B9 KR 102324922 B9 KR102324922 B9 KR 102324922B9 KR 1020200102684 A KR1020200102684 A KR 1020200102684A KR 20200102684 A KR20200102684 A KR 20200102684A KR 102324922 B9 KR102324922 B9 KR 102324922B9
Authority
KR
South Korea
Prior art keywords
osteocalcin
preventing
pharmaceutical composition
inflammatory diseases
treating inflammatory
Prior art date
Application number
KR1020200102684A
Other languages
English (en)
Other versions
KR20200102392A (ko
KR102324922B1 (ko
Inventor
백경화
박단비
Original Assignee
주식회사 제너로스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180033977A external-priority patent/KR20190111612A/ko
Application filed by 주식회사 제너로스 filed Critical 주식회사 제너로스
Priority to KR1020200102684A priority Critical patent/KR102324922B1/ko
Publication of KR20200102392A publication Critical patent/KR20200102392A/ko
Application granted granted Critical
Publication of KR102324922B1 publication Critical patent/KR102324922B1/ko
Publication of KR102324922B9 publication Critical patent/KR102324922B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020200102684A 2018-03-23 2020-08-14 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물 KR102324922B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200102684A KR102324922B1 (ko) 2018-03-23 2020-08-14 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180033977A KR20190111612A (ko) 2018-03-23 2018-03-23 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물
KR1020200102684A KR102324922B1 (ko) 2018-03-23 2020-08-14 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020180033977A Division KR20190111612A (ko) 2018-03-23 2018-03-23 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물

Publications (3)

Publication Number Publication Date
KR20200102392A KR20200102392A (ko) 2020-08-31
KR102324922B1 KR102324922B1 (ko) 2021-11-11
KR102324922B9 true KR102324922B9 (ko) 2022-01-17

Family

ID=72234150

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200102684A KR102324922B1 (ko) 2018-03-23 2020-08-14 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물

Country Status (1)

Country Link
KR (1) KR102324922B1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748610A (zh) * 2022-04-13 2022-07-15 中国科学院深圳先进技术研究院 骨钙素在制备抗炎药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2073832B1 (en) 2006-09-13 2013-09-04 The Trustees of Columbia University in the City of New York Undercarboxylated/uncarboxylated osteocalcin increases beta-cell proliferation, insulin secretion, insulin sensitivity, glucose tolerance and decreases fat mass
CN101674839A (zh) * 2007-03-06 2010-03-17 宝生物工程株式会社 制备含骨钙素提取物的方法
KR101595063B1 (ko) * 2014-04-24 2016-02-18 단국대학교 천안캠퍼스 산학협력단 세포결합 서열, 헤파린 결합 도메인 및 오스테오칼신 도메인을 포함하는 융합단백질 및 이를 포함하는 약학 조성물

Also Published As

Publication number Publication date
KR20200102392A (ko) 2020-08-31
KR102324922B1 (ko) 2021-11-11

Similar Documents

Publication Publication Date Title
SI3600309T1 (sl) Terapevtske kombinacije za zdravljenje bolezni jeter
SG11201801024XA (en) Therapeutic or preventive compositions for il-8-related diseases
IL279260A (en) KDM1A inhibitors for the treatment of diseases
EP3826666A4 (en) COMPOSITIONS AND METHODS OF TREATING DISEASES ASSOCIATED WITH NRP2
IL269158A (en) Preparations and methods for the treatment of inflammatory diseases
KR102223657B9 (ko) 염증성 장질환 예방 또는 치료용 약학적 조성물
IL278041A (en) Bezumab formulations with a buffer for use in the treatment of diseases
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
ZA202100703B (en) Compositions and methods for treating inflammasome related diseases or conditions
EP3275450A4 (en) Pharmaceutical composition for preventing or treating inflammatory diseases, containinglactococcus chungangensis
ZA201907238B (en) Compositions for treating neurodegenerative diseases
EP3685840A4 (en) PHARMACEUTICAL COMPOSITION OF COMPOUNDS FOR TREATING INFLAMMATORY SKIN DISEASES
IL286767A (en) Preparations and methods of their use for the treatment of neurodegenerative and mitochondrial diseases
IL280600A (en) A new drug for the treatment of inflammatory bowel diseases
EP3428178A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
GB201518456D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases
IL290770A (en) Compounds and methods for treating oxalate-related diseases
EP3827837A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF IMMUNE DISEASES
SG10201912046VA (en) Pharmaceutical composition for preventing or treating regulatory t cell-mediated diseases
EP3768095A4 (en) Compositions and methods for treating diarrheal diseases
PT3810128T (pt) Composições para tratar e/ou prevenir doenças de agregação de proteinas
KR102324922B9 (ko) 오스테오칼신을 포함하는 염증성 질환의 예방 또는 치료용 약학 조성물
EP3672583A4 (en) COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
EP3428179A4 (en) PEPTIDE FOR THE PREVENTION OR TREATMENT OF INFLAMMATORY DISEASES AND USE THEREOF
KR102316727B9 (ko) 아토피성 질환 예방 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
A107 Divisional application of patent
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
G170 Publication of correction